veterinari
medicin
consid
prophylact
vaccin
combin
strict
biosecur
costeffect
tool
prevent
viral
infect
gener
veterinari
viral
vaccin
aim
protect
suscept
host
anim
fatal
infecti
diseas
induc
rapid
longlast
immun
respons
prevent
spread
diseas
among
popul
reduc
viral
shed
infect
anim
vaccin
must
costeffect
stabl
easi
administ
live
attenu
viru
andor
inactiv
viru
vaccin
use
decad
prevent
viral
infecti
diseas
howev
mani
vaccin
satisfi
requir
ideal
vaccin
field
due
limit
effect
andor
side
effect
addit
vaccin
avail
infecti
diseas
advanc
recombin
dna
technolog
made
possibl
design
new
innov
genet
engin
vaccin
improv
safeti
profil
greater
protect
efficaci
next
gener
vaccin
includ
dna
vaccin
subunit
viruslik
particl
vaccin
genet
modifi
marker
vaccin
viru
vector
vaccin
latter
thought
promis
tool
develop
polyval
antigen
deliveri
vaccin
express
foreign
antigen
deriv
pathogen
econom
import
veterinari
human
perspect
mani
virus
use
develop
viru
vector
vaccin
provid
effect
protect
immun
foreign
antigen
number
vector
vaccin
licens
veterinari
human
use
increas
time
initi
vector
vaccin
base
dna
virus
herpesvirus
anim
poxvirus
adenovirus
current
advanc
revers
genet
approach
mani
rna
virus
adapt
use
vector
vaccin
vaccin
vector
includ
positivesens
rna
virus
picornavirus
coronavirus
flavivirus
negativesens
rna
virus
paramyxovirus
orthomyxovirus
particular
newcastl
diseas
viru
ndv
paramyxoviru
infect
bird
use
import
vaccin
vector
develop
bival
vaccin
pathogen
econom
import
poultri
industri
numer
studi
demonstr
ndv
promis
vector
deliveri
protect
antigen
deriv
pathogen
infect
mammal
human
inde
ndv
vector
safer
effici
convent
whole
viru
vaccin
articl
review
recent
develop
field
ndvvector
vaccin
potenti
use
vaccin
veterinari
human
medicin
virul
ndv
caus
agent
newcastl
diseas
nd
result
devast
econom
loss
poultri
industri
worldwid
particularli
asia
middl
east
africa
control
nd
poultri
flock
subject
prophylact
vaccin
live
attenu
andor
kill
ndv
vaccin
gallinac
bird
eg
chicken
quail
turkey
highli
suscept
ndv
although
viru
infect
bird
speci
clinic
sever
chicken
vari
greatli
depend
virul
ndv
isol
base
effect
chicken
isol
ndv
classifi
least
four
pathotyp
velogen
highli
pathogen
form
mesogen
moder
pathogen
form
lentogen
low
pathogen
form
avirul
subclin
form
lentogen
eg
lasota
avirul
eg
vgga
virus
wide
use
vaccin
prevent
nd
poultri
ndv
avian
paramyxoviru
type
viru
belong
genu
avulaviru
within
famili
paramyxovirida
viru
contain
nonseg
negativesens
singlestrand
rna
genom
nucleotid
length
encod
six
structur
protein
nucleocapsid
n
protein
phosphor
p
protein
matrix
protein
fusion
f
protein
hemagglutininneuraminidas
hn
protein
rnadepend
rna
polymeras
l
protein
length
ndv
genom
follow
rule
six
allow
effici
viru
replic
n
protein
bind
effect
six
nucleotid
fig
show
schemat
diagram
ndv
morpholog
ndv
f
hn
glycoprotein
major
structur
protein
compris
bilay
lipid
membran
envelop
play
import
role
viru
attach
entri
releas
protein
resid
beneath
envelop
involv
assembl
bud
n
protein
bind
genom
rna
form
nucleocapsid
nc
core
p
l
protein
associ
nc
core
form
ribonucleoprotein
rnp
complex
essenti
viru
replic
transcript
two
nonstructur
protein
v
w
produc
rna
edit
p
gene
one
v
two
w
g
residu
insert
specif
locat
within
mrna
encod
p
gene
v
protein
interferon
ifn
antagonist
life
cycl
ndv
occur
entir
cytoplasm
first
ndv
enter
cell
cytoplasm
via
viral
attach
subsequ
membran
fusion
mediat
hn
f
protein
respect
viral
nc
rnp
complex
releas
cytoplasm
whereupon
rnp
complex
transcrib
viral
rna
produc
viral
mrna
translat
viral
protein
genom
replic
occur
suffici
viral
protein
especi
n
protein
synthes
fulllength
antigenom
rna
plusstrand
serv
templat
synthesi
viral
rna
genom
minusstrand
newli
form
genom
rna
encapsid
n
protein
associ
polymeras
complex
viral
compon
transport
cell
membran
assembl
progeni
viru
particl
progeni
acquir
envelop
bud
direct
protein
releas
cell
surfac
process
detach
elut
regul
hn
protein
neuraminidas
activ
ndv
negativesens
singlestrand
rna
viru
function
viral
rnp
complex
requir
viral
transcript
replic
thu
revers
genet
technolog
use
gener
recombin
ndv
rndv
requir
fulllength
complementari
dna
cdna
clone
three
helper
plasmid
encod
ndv
n
p
l
protein
transcript
control
rna
polymeras
promot
simultan
transfect
permiss
cell
three
helper
plasmid
express
n
p
l
protein
bind
genom
antigenom
rna
form
rnp
complex
gener
revers
genet
approach
use
rescu
rndv
base
one
three
differ
system
chicken
fibroblast
cell
cell
line
fowl
pox
recombin
system
rna
polymeras
express
bsr
babi
hamster
cell
clone
system
human
epidermoid
carcinoma
cell
hostrestrict
recombin
vaccinia
viru
modifi
vaccinia
viru
ankara
mva
system
fig
depict
revers
genet
system
use
laboratori
briefli
cell
infect
mva
cotransfect
ndv
cdna
clone
lasota
backbon
three
helper
plasmid
n
p
l
recov
virus
purifi
cell
plaqu
assay
clone
select
passag
sever
time
specif
pathogen
free
spf
embryon
chicken
egg
insert
foreign
gene
fulllength
cdna
clone
pivot
step
gener
rndv
express
foreign
antigen
manipul
cdna
clone
express
foreign
antigen
must
take
sever
factor
account
foreign
gene
interest
synthes
transcript
unit
compris
gene
start
gs
sequenc
foreign
gene
gene
end
sequenc
fig
transcript
unit
insert
noncod
intergen
region
ndv
genom
number
nucleotid
make
rndv
genom
must
follow
rule
six
ensur
integr
genom
effici
viru
replic
insert
site
one
import
factor
affect
effici
express
foreign
gene
gener
gene
closer
terminu
transcrib
abundantli
downstream
gene
transcript
gradient
due
imperfect
restart
transcript
gs
word
foreign
gene
express
abundantli
effici
place
closer
end
genom
foreign
gene
place
intergen
site
within
ndv
genom
pm
intergen
site
prefer
ensur
optim
express
foreign
gene
length
insert
foreign
gene
also
affect
effici
express
foreign
antigen
incorpor
foreign
gene
increas
size
genom
number
transcript
unit
within
genom
often
lead
retard
growth
rndv
permiss
cell
singl
ndv
vector
accommod
foreign
gene
kb
length
good
degre
stabil
express
least
three
differ
foreign
gene
ndv
vaccin
use
develop
antigen
deliveri
vaccin
use
cattlesheep
dogscat
pig
hors
tabl
antigen
deliveri
vaccin
veterinari
use
includ
protect
bovin
herpesviru
bovin
ephemer
fever
viru
befv
rift
valley
fever
viru
rvfv
vesicular
stomat
viru
vsv
canin
distemp
viru
cdv
rabi
viru
rv
nipah
viru
niv
west
nile
viru
wnv
major
caus
respiratori
tract
diseas
cattl
major
problem
current
modifi
live
vaccin
abil
caus
latent
infect
associ
risk
subsequ
reactiv
altern
strategi
khattar
et
al
develop
rndv
vaccin
rlasotagdfl
express
gd
singl
intranasalintratrach
immun
rlasotagdfl
pfudos
induc
mark
mucos
system
antibodi
respons
calv
also
intranas
challeng
high
dose
virul
strain
cooper
pfu
led
mark
reduct
viral
shed
rapid
clearanc
challeng
viru
compar
mockinfect
challeng
control
result
suggest
ndv
may
util
vaccin
vector
use
develop
mucos
vaccin
infect
cattl
rvfv
mosquitoborn
bunyaviru
infect
rumin
cattl
sheep
caus
sever
econom
loss
livestock
industri
high
impact
public
health
africa
arabian
peninsula
current
live
attenu
vaccin
smithburn
strain
inactiv
rvfv
vaccin
avail
howev
although
live
attenu
vaccin
highli
immunogen
safe
use
livestock
inactiv
vaccin
safer
less
effect
live
attenu
vaccin
requir
repeat
vaccin
improv
efficaci
safeti
kortekaa
et
al
develop
ndvvector
vaccin
ndflgngc
express
gn
gc
glycoprotein
rvfv
repeat
vaccin
two
time
lamb
ndflgngc
vaccin
elicit
high
titer
neutral
antibodi
specif
rvfv
result
indic
ndv
potenti
vaccin
vector
sheep
rv
rhabdoviru
infect
dog
caus
fatal
neurolog
diseas
rabi
human
anim
peopl
die
rabi
year
death
occur
asia
africa
current
avail
live
attenu
rv
vaccin
induc
weak
humor
antibodi
respons
complic
evalu
efficaci
gener
live
attenu
vaccin
improv
efficaci
ndvvector
rabi
vaccin
rlrvg
contain
rv
g
glycoprotein
develop
anim
experi
demonstr
rlrvg
induc
product
rv
neutral
antibodi
level
compar
induc
live
attenu
rv
vaccin
era
strain
provid
complet
protect
challeng
potenti
fatal
viru
strain
year
ndv
vaccin
strain
use
viru
vector
develop
antigen
deliveri
vaccin
use
human
tabl
human
ndv
vector
vaccin
develop
includ
human
immunodefici
viru
influenza
viru
highli
pathogen
avian
influenza
viru
hpaiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
ebola
viru
ebov
niv
human
noroviru
nov
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
current
live
attenu
vaccin
avail
howev
ndv
use
vaccin
vector
deliv
env
gag
antigen
hiv
exampl
khattar
et
al
develop
two
ndvvector
hiv
vaccin
rndvgagenv
rndvenvgag
express
env
gag
respect
gene
insert
p
gene
ndv
intranas
immun
guinea
pig
vaccin
induc
longlast
env
gagspecif
humor
immun
respons
also
induc
mark
effici
cellular
protect
immun
respons
mice
challeng
vaccinia
virus
express
env
gag
result
suggest
vaccin
singl
ndv
vector
coexpress
env
gag
promis
strategi
increas
vaccin
immunogen
subsequ
protect
efficaci
hiv
ndvvector
vaccin
may
use
human
influenza
virus
nakaya
et
al
develop
ndvvector
human
influenza
vaccin
express
ha
protein
influenza
viru
two
intraven
inocul
mice
vaccin
pfudos
induc
strong
antiinfluenza
viru
antibodi
respons
provid
complet
protect
lethal
challeng
influenza
viru
recent
dinapoli
et
al
develop
ndvvector
hpaiv
vaccin
ndvha
express
ha
protein
hpaiv
use
human
protect
efficaci
hpaiv
evalu
african
green
monkey
model
two
oronas
administr
ndvha
pfudos
induc
high
serum
titer
hpaiv
neutral
antibodi
robust
mucos
immunoglobulin
respons
respiratori
tract
result
suggest
ndvha
may
effect
human
vaccin
hpaiv
ndvvector
vaccin
also
use
develop
vaccin
deadli
emerg
virus
virus
includ
sarscov
ebov
niv
exampl
kong
et
al
develop
one
ndvvector
niv
vaccin
express
niv
glycoprotein
rlanivg
one
express
f
protein
rlanivf
evalu
immunogen
pig
model
show
two
intramuscular
vaccin
rlanivf
elicit
high
titer
nivspecif
neutral
antibodi
maximum
titer
pig
neutral
antibodi
persist
least
week
post
vaccin
indic
potenti
util
vector
vaccin
protect
human
pig
niv
infect
ndv
also
use
vaccin
vector
develop
vaccin
human
virus
whole
viru
vaccin
avail
due
inabl
grow
target
virus
eg
human
papillomavirus
hepat
c
viru
nov
cell
cultur
exampl
kim
et
al
develop
ndvvector
nov
vaccin
modifi
vaccin
express
capsid
protein
nov
strain
human
use
modifi
grew
high
titer
embryon
chicken
egg
pfuml
produc
high
level
protein
allanto
fluid
express
protein
selfassembl
viruslik
particl
three
inocul
modifi
vaccin
induc
strong
immun
respons
along
high
level
tumor
necrosi
factoralpha
interleukin
product
splenocyt
mice
strong
fecal
iga
respons
also
note
suggest
modifi
vaccin
potenti
live
attenu
vaccin
nov
human
addit
ndvvector
vaccin
also
promis
strategi
human
respiratori
virus
includ
rsv
taken
togeth
result
suggest
primari
vaccin
ndvvector
vaccin
express
foreign
protein
effect
howev
efficaci
updat
new
vaccin
base
ndv
vector
may
reduc
preexist
ndv
antibodi
could
limit
continu
use
ndv
vector
vaccin
human
global
epizoot
episod
hpaiv
wild
bird
poultri
potenti
caus
pandem
human
driven
develop
effect
hpaiv
vaccin
aim
maintain
food
secur
reduc
viral
load
environ
sinc
vaccin
program
design
protect
poultri
hpaiv
implement
sever
countri
viru
enzoot
includ
china
hong
kong
egypt
indonesia
vietnam
gener
convent
highli
pathogen
avian
influenza
hpai
vaccin
poultri
compris
kill
viru
prepar
low
pathogen
strain
recent
revers
genet
engin
low
pathogen
reassort
viru
deriv
hemagglutinin
ha
neuraminidas
gene
fieldvirul
viru
six
intern
gene
apuerto
kill
avian
influenza
viru
aiv
vaccin
limit
includ
high
product
cost
poor
immunogen
problem
mass
vaccin
administr
live
attenu
aiv
vaccin
poultri
strictli
prohibit
due
risk
emerg
variant
aris
revers
virul
via
antigen
drift
antigen
shift
presenc
circul
field
virus
ndvvector
aiv
vaccin
bival
live
attenu
vaccin
suitabl
mass
vaccin
poultri
commerci
scale
proven
safeti
profil
basic
ndvvector
ai
vaccin
design
express
ha
protein
aiv
critic
protect
tabl
date
ndvvector
aiv
vaccin
administ
poultri
china
mexico
china
approxim
billion
dose
ndvvector
aiv
vaccin
use
prevent
hpai
ha
gene
initi
incorpor
ndv
vector
replac
ha
gene
recent
approxim
million
dose
ndvvector
ai
vaccin
use
mexico
form
live
vaccin
kill
vaccin
prevent
lpai
poultri
juli
octob
mexican
vaccin
express
ha
gene
low
pathogen
avian
influenza
viru
ndv
vector
vaccin
express
ha
gene
hpaiv
show
high
protect
efficaci
hpaiv
virul
ndv
experiment
spf
chicken
howev
field
condit
breeder
maintain
high
level
immun
ndv
multipl
vaccin
ensur
progeni
chick
matern
antibodi
ndv
first
week
life
howev
presenc
matern
antibodi
could
interfer
efficaci
ndvvector
aiv
vaccin
result
poor
antibodi
respons
ndv
aiv
ha
altern
strategi
chimer
ndvvector
vaccin
ectodomain
f
hn
protein
replac
anoth
avian
paramyxoviru
serotyp
develop
bival
ndvvector
vaccin
develop
prevent
diseas
econom
import
poultri
industri
advantag
tradit
vaccin
tabl
exampl
includ
infecti
bursal
diseas
viru
ibdv
infecti
bronchiti
viru
ibv
infecti
laryngotrach
viru
iltv
avian
metapneumoviru
ampv
ibdv
birnaviru
infect
chicken
import
pathogen
caus
sever
immunosuppress
high
mortal
young
chicken
live
attenu
vaccin
moder
virul
especi
wide
use
intermedi
plu
vaccin
use
wide
prevent
infecti
bursal
diseas
ibd
howev
caus
sever
side
effect
symptom
consist
ibd
young
chicken
huang
et
al
develop
ndvvector
ibdv
vaccin
express
gene
ibdv
respons
protect
immun
ibdv
gene
insert
noncod
region
ndv
genom
live
ibv
vaccin
safe
young
chicken
protect
spf
chicken
virul
ndv
virul
ibdv
ibv
coronaviru
infect
bird
caus
respiratori
diseas
renal
disord
nephropathogen
strain
poultri
poor
egg
product
lay
hen
worldwid
current
avail
live
attenu
ibv
vaccin
risk
give
rise
new
variant
recombin
field
ibv
often
reduc
efficaci
ibv
vaccin
importantli
live
ibv
vaccin
interfer
live
attenu
ndv
vaccin
overcom
limit
current
avail
live
vaccin
toro
et
al
develop
ndvvector
ibv
vaccin
express
subunit
ibv
glycoprotein
oculonas
immun
chicken
provid
complet
protect
clinic
diseas
mortal
challeng
lethal
dose
virul
ndv
protect
efficaci
vaccin
also
assess
use
heterotyp
protect
approach
base
prime
live
attenu
ibv
masstyp
vaccin
follow
boost
vaccin
protect
chicken
clinic
diseas
lethal
challeng
virul
arktyp
ibv
strain
lead
signific
reduct
viru
shed
compar
unvaccinatedchalleng
chicken
iltv
herpesviru
infect
bird
caus
respiratori
diseas
chicken
current
avail
live
attenu
iltv
vaccin
effect
concern
safeti
chicken
risk
virul
acquir
latent
infect
bird
bird
transmiss
bival
ndvvector
vaccin
iltv
develop
overcom
side
effect
associ
live
iltv
vaccin
kanabagatt
basavarajappa
et
al
develop
ndvvector
iltv
vaccin
rndv
gd
express
glycoprotein
gd
iltv
protect
efficaci
rndv
gd
vaccin
challeng
virul
iltv
virul
ndv
evalu
spf
chicken
immun
chicken
rndv
gd
via
oronas
rout
induc
strong
antibodi
respons
provid
high
level
protect
subsequ
challeng
virul
iltv
ndv
indic
rndv
gd
potenti
bival
vaccin
ndv
vaccin
strain
show
promis
base
develop
effect
vaccin
pathogen
infect
anim
human
ndvvector
vaccin
use
poultri
bival
provid
protect
efficaci
virul
ndv
sever
foreign
pathogen
ndvvector
poultri
vaccin
develop
provid
protect
hpaiv
ibdv
iltv
ibv
ampv
safe
ndvvector
vaccin
develop
antigen
deliveri
vaccin
veterinari
human
use
vaccin
express
foreign
target
antigen
induc
robust
immun
respons
local
system
level
shown
ndvvector
veterinari
vaccin
cattlesheep
eg
befv
rvfv
vsv
dogscat
eg
cdv
rv
pig
eg
niv
hors
eg
wnv
ndvvector
human
vaccin
current
develop
aim
provid
protect
hiv
rsv
newli
emerg
zoonot
virus
eg
hpaiv
sarscov
ebov
niv
noncultiv
human
virus
eg
human
papillomaviru
hepat
c
viru
nov
primari
vaccin
ndvvector
vaccin
express
foreign
protein
effect
efficaci
updat
new
vaccin
base
ndv
vector
may
reduc
preexist
ndv
antibodi
could
limit
continu
use
ndv
vector
vaccin
human
conclus
ndv
vaccin
strain
attract
vector
use
develop
effect
vaccin
pathogen
infect
anim
andor
human
vaccin
safe
effici
provid
high
level
protect
immun
although
risk
previou
vaccin
reduc
efficaci
vector
vaccin
